Studio LSD (STUDIOLSD)

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹12, Studio LSD carries a market cap of only ₹52 crore. In normal times a P/E of 44.73 would already demand exceptional growth, but this is not a normal time. Sales have fallen 37.20%, profit growth is -149.64%, and the latest quarter shows a net loss of ₹3 crore on revenue of ₹39 crore. The Piotroski F-Score of 3/9 reinforces the picture: deteriorating fundamentals, poor profitability, and weak financial health. The reported ROCE of 72.75% looks striking, but it is backward-looking; current losses tell me it is not translating into shareholder earnings. With no dividend, no book value, and no debt/equity data, I lack the margin of safety that Graham always insisted upon. A 73.50% promoter holding can be positive—it aligns owners with minority shareholders—but it cannot offset negative earnings and shrinking sales. Value investors do not pay 44 times earnings for a business in this condition. This is not a fast grower or stalwart; it is a small Indian media and entertainment player that may be in need of a turnaround. I would not deploy capital today. I would wait for evidence that quarterly losses narrow, that revenue growth stabilizes, and that the company can generate positive free cash flow. Without those proof points, the cheap-looking ₹12 price is not cheap; it simply reflects falling earnings. Benjamin Graham said price is what you pay, value is what you get. Here, the value is not visible from the data.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer